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Abstract: Listeria monocytogenes can persist in food production facilities, resulting in serious threats
to consumers due to the high mortality associated with listeriosis, especially in the very young,
old and pregnant. We subtyped 124 strains of L. monocytogenes isolated from a meat processing
facility in Switzerland by serotyping, multi locus sequence typing (MLST) typing and whole genome
sequencing. We then analyzed their ability to form biofilms and their resistance to the disinfectants
benzalkonium chloride (BC) and peracetic acid (PAA). The genotyping results of the strains showed
that several clonal populations of L. monocytogenes belonging to CC9, CC204 and CC121 had persisted
in this meat processing facility for at least four years. All of the strains showed biofilm forming
capacity comparable to a known high biofilm forming strain. Known efflux pumps for BC were
present in CC204, CC9 (brcABC) and CC121 (qacH) strains, while strains from other CC showed very
low minimal inhibitory concentrations (MICs) for BC. For PAA, minimal bactericidal concentrations
of 1.2–1.6% for 20 min and minimal inhibitory concentrations between 0.1 and 0.2% were observed.
These values were close to or above the recommended concentration for use (0.5–1%), suggesting
that PAA might be ineffective at controlling L. monocytogenes in this and potentially other meat
processing facilities.
Keywords: Listeria monocytogenes; meat processing facility; persistence; benzalkonium chloride;
peracetic acid; biofilm
1. Introduction
Listeria monocytogenes is a food-borne pathogen that causes disease mainly in vulnerable
populations such as very young, old, pregnant or immunocompromised individuals. The high
mortality rate of 15–30 deaths per 100 cases of listeriosis [1–4] is mostly attributable to severe central
nervous system infections, septicemia, abortions and neonatal listeriosis. In the United States alone,
listeriosis is estimated to cause an annual loss of 8800 disease adjusted live years (DALY), of which the
majority are premature deaths [5].
Human cases of listeriosis often trace back to food products that were contaminated during
production, with subsequent growth of L. monocytogenes to high numbers. Ready-to-eat products such
as salads or deli meat are of special concern due to the lack of a heating step prior to consumption.
The frequent occurrence of L. monocytogenes in the environment results in a high probability of
introducing the organism into facilities, either on raw materials, through equipment or via employees.
Once introduced, several factors increase the probability of a strain being able to establish long-lasting
colonization of niches. L. monocytogenes has a high tolerance against acid and salt stress, and is able to
grow at refrigerating temperatures. In addition, the ability to form biofilms may enhance survival,
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especially in niches that are difficult to reach during cleaning procedures. Further, tolerance against
commonly used disinfectants such as the quaternary ammonium chloride compound benzalkonium
chloride were observed in L. monocytogenes isolates from food processing environments [6–11].
Accordingly, L. monocytogenes presents a challenge to the food industry and has been shown to
persist in food producing facilities for long periods of time, in some cases for more than a decade.
For example, a meat factory in Texas harbored the same strain for at least 12 years, eventually causing
an outbreak in 2000 [6,7]. A smoked fish processing plant harbored the same strain of L. monocytogenes
for 11 years [8]. A study in Ireland found that seven out of 48 food processors housed a persistent
strain—defined as isolated at least six months apart [9].
Here, we analyzed strains from a Swiss deli meat plant where L. monocytogenes strains were
repeatedly isolated between 2015 and 2018. The aim was (i) to determine whether a clonal population
of L. monocytogenes persisted in the facility or if L. monocytogenes was repeatedly reintroduced, and (ii),
to characterize the resistance of the collected strains against benzalkonium chloride (BC) and peracetic
acid (PAA) and their ability to form biofilms.
2. Results
2.1. Subtyping of 124 Listeria Monocytogenes Isolated from a Swiss Meat Plant
A total of 124 strains of L. monocytogenes were analyzed in this study. All strains were collected
in the framework of a hygiene monitoring program in a meat processing facility in Switzerland
between 2015 and 2018 (Table 1). The collection contains four strains from 2015, three strains from
2016, 32 strains from 2017 and 85 strains from 2018. The samples originated from products (n = 8) and
from the food production environment (n = 116).
In a first screening of the diversity of the 124 L. monocytogenes strains, their serogroup and multi
locus sequence typing (MLST) profile was determined. The majority of the strains (n = 73, 58.9%)
belonged to serogroup II (containing serotype 1/2c, 3c), 48 strains (38.7%) belonged to serogroup I
(1/2a, 3a) and three strains (2.4%) belonged to serogroup IV (4b, 4d, 4e). Seven gene MLST revealed
that all of the 73 serogroup II strains belonged to CC9 (n = 73, 58.9%). The strains belonging to
serogroup I were more heterogenous with 31 strains assigned to CC204, seven strains assigned to
CC121, four strains to CC20 and to CC29, and one to CC8 and to CC89. The three strains in serogroup
IV all belonged to CC6. Only strains from CC9, CC204 and CC121 were consistently isolated over all
four years. CC6 strains seem to have been introduced into the facility in July 2017 and persisted until
the end of the sampling period in June 2018.
From these results we concluded that it was likely that clonal populations of CC9, CC204, CC121,
and CC6 persisted in this facility, while strains from other complexes were sporadically introduced
and deemed “presumably non-persistent”. We consciously use the term “presumably” because there
is no reasonable way to determine if those strains would have persisted in different environments or
under different growth conditions.
In a next step, the genomes of 20 strains were sequenced and a core genome MLST (cgMLST)
comparison was performed (Figure 1). The cgMLST revealed that most strains from the same CC
differed in less than 10 alleles, a cutoff for strain clonality [10].
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Table 1. L. monocytogenes strains used in this study.
Strain Isolation Date Source Purpose Serogroup Sequence Type CC WGS brcABC qacH emrE Lineage
ILS AS1-0001 2015/10/15 FPE Study strain 2 9 9 1 absent absent absent II
ILS AS1-0002 2015/10/19 FP Study strain 1 121 121 n/a n/a n/a II
ILS AS1-0003 2015/11/9 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0004 2015/11/14 FPE Study strain 1 204 204 2* present absent absent II
ILS AS1-0005 2016/2/2 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0006 2016/3/9 FPE Study strain 1 121 121 3* absent present absent II
ILS AS1-0007 2016/10/20 FP Study strain 1 204 204 2 present absent absent II
ILS AS1-0008 2017/1/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0009 2017/1/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0010 2017/1/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0011 2017/1/9 FPE Study strain 2 9 9 1 present absent absent II
ILS AS1-0012 2017/1/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0013 2017/1/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0014 2017/1/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0015 2017/6/26 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0016 2017/6/29 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0017 2017/7/7 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0018 2017/7/7 FPE Study strain 4 6 6 4 absent absent absent I
ILS AS1-0019 2017/8/10 FP Study strain 1 121 121 3 absent present absent II
ILS AS1-0020 2017/9/12 FP Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0021 2017/9/13 FP Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0022 2017/9/18 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0023 2017/9/18 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0024 2017/11/6 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0025 2017/11/6 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0026 2017/11/13 FPE Study strain 1 204 204 1 absent absent absent II
ILS AS1-0027 2017/11/23 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0028 2017/12/5 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0029 2017/12/5 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0030 2017/12/5 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0031 2017/12/5 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0032 2017/12/7 FPE Study strain 1 20 20 n/a n/a n/a II
ILS AS1-0033 2017/12/7 FPE Study strain 1 20 20 n/a n/a n/a II
ILS AS1-0034 2017/12/7 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0035 2017/12/5 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0036 2017/12/5 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0037 2017/12/5 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0038 2017/12/5 FPE Study strain 2 9 9 1 absent absent absent II
ILS AS1-0039 2017/12/14 FPE Study strain 1 121 121 3 absent present absent II
ILS AS1-0040 2018/1/23 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0041 2018/1/23 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0042 2018/1/23 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0043 2018/1/23 FPE Study strain 1 29 29 n/a n/a n/a II
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Table 1. Cont.
Strain Isolation Date Source Purpose Serogroup Sequence Type CC WGS brcABC qacH emrE Lineage
ILS AS1-0044 2018/1/23 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0045 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0046 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0047 2018/1/25 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0048 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0049 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0050 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0051 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0052 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0053 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0054 2018/1/25 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0055 2018/1/25 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0056 2018/1/25 FPE Study strain 1 204 204 2 present absent absent II
ILS AS1-0057 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0058 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0059 2018/1/25 FPE Study strain 2 9 9 1 present absent absent II
ILS AS1-0060 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0061 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0062 2018/1/26 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0063 2018/1/26 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0064 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0065 2018/1/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0066 2018/1/25 FPE Study strain 1 391 89 n/a n/a n/a II
ILS AS1-0067 2018/2/6 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0068 2018/2/6 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0069 2018/2/7 FPE Study strain 1 29 29 n/a n/a n/a II
ILS AS1-0070 2018/2/6 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0071 2018/2/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0072 2018/2/9 FPE Study strain 2 9 9 1 present absent absent II
ILS AS1-0073 2018/2/9 FPE Study strain 4 6 6 4 absent absent absent I
ILS AS1-0074 2018/2/9 FPE Study strain 1 29 29 n/a n/a n/a II
ILS AS1-0075 2018/2/9 FPE Study strain 1 8 8 n/a n/a n/a II
ILS AS1-0076 2018/2/9 FPE Study strain 1 20 20 n/a n/a n/a II
ILS AS1-0077 2018/2/9 FPE Study strain 1 29 29 n/a n/a n/a II
ILS AS1-0078 2018/2/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0079 2018/2/9 FPE Study strain 1 121 121 n/a n/a n/a II
ILS AS1-0080 2018/2/9 FPE Study strain 1 121 121 3 absent present absent II
ILS AS1-0081 2018/2/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0082 2018/2/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0083 2018/2/9 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0084 2018/2/9 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0085 2018/2/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0086 2018/2/9 FPE Study strain 1 20 20 n/a n/a n/a II
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Table 1. Cont.
Strain Isolation Date Source Purpose Serogroup Sequence Type CC WGS brcABC qacH emrE Lineage
ILS AS1-0087 2018/2/9 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0088 2018/2/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0089 2018/2/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0090 2018/2/9 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0091 2018/2/10 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0092 2018/2/13 FPE Study strain 2 9 9 1 present absent absent II
ILS AS1-0093 2018/3/21 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0094 2018/4/5 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0095 2018/4/5 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0096 2018/4/5 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0097 2018/4/5 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0098 2018/5/22 FPE Study strain 1 204 204 2 present absent absent II
ILS AS1-0099 2018/5/22 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0100 2018/3/21 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0101 2018/5/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0102 2018/5/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0103 2018/5/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0104 2018/5/25 FPE Study strain 2 9 9 present absent absent II
ILS AS1-0105 2018/5/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0106 2018/5/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0107 2018/5/25 FPE Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0108 2018/5/25 FPE Study strain 4 6 6 n/a n/a n/a I
ILS AS1-0109 2018/6/19 FP Study strain 2 9 9 n/a n/a n/a II
ILS AS1-0110 2018/6/25 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0111 2018/6/25 FPE Study strain 1 204 204 2 present absent absent II
ILS AS1-0112 2018/6/26 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0113 2018/6/26 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0114 2018/6/26 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0115 2018/6/26 FPE Study strain 1 204 204 2 present absent absent II
ILS AS1-0116 2018/6/26 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0117 2018/6/26 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0118 2018/6/26 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0119 2028/6/25 FP Study strain 2 9 9 1 present absent absent II
ILS AS1-0120 2018/7/16 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0121 2018/7/16 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0122 2018/7/16 FPE Study strain 1 204 204 n/a n/a n/a II
ILS AS1-0123 2018/8/3 FP Study strain 1 121 121 n/a n/a n/a II
ILS AS1-0124 2018/8/9 FPE Study strain 1 204 204 n/a n/a n/a II
ILS-AS-R-001 PAA reference 204 204 n/a n/a n/a II
ILS-AS-R-002 PAA reference 204 204 n/a n/a n/a II
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Table 1. Cont.
Strain Isolation Date Source Purpose Serogroup Sequence Type CC WGS brcABC qacH emrE Lineage
ILS-AS-R-003 PAA reference 204 204 n/a n/a n/a II
ILS-AS-R-004 PAA reference 9 9 n/a n/a n/a II
ILS-AS-R-005 PAA reference 9 9 n/a n/a n/a II
ILS-AS-R-006 PAA reference 9 9 n/a n/a n/a II
ILS-AS-R-007 PAA reference 9 9 n/a n/a n/a II
ILS-AS-R-008 PAA reference 121 121 n/a n/a n/a II
ILS-AS-R-009 PAA reference 6 6 n/a n/a n/a I
N586 LBF 3a◦ 412 412 n/a n/a n/a II
N11-1850 HBF 4b◦ 1290 217 n/a n/a n/a I
* indicates strains that are associated with a cgMLST cluster without being properly in it. These strains were serotyped with antibodies from Denka-Seiken (Basel, Switzerland). n/a = not
applicable; LBF = low biofilm former; HBF = high biofilm former; CC = clonal complex; WGS = core genome multi locus sequencing (cgMLST) cluster; FPE = food processing environment;
FP = food product.
Table 2. Nucleotides used in this study.
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2.2. Biofilm Formation
The capacity to form biofilms is an important mechanism for persistence [11], and biofilm
formation might have contributed to the maintained presence of clonal clusters of L. monocytogenes
strains in the facility for years. We therefore investigated the biofilm forming ability in a subset of
strains of the collective (CC9, CC204, CC121 and CC6) at 22 and 8 ◦C.
Approximately double the biofilm mass was recovered after 96 h of growth at 22 ◦C compared to
168 h growth at 8 ◦C (p < 0.01) (Figure 2). However, no individual strain had significantly different
biofilm formation compared to the other tested strains (Supplementary File 1).
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At 22 ◦C, strains from CC9, CC204, CC121 and CC6 showed a biofilm forming capacity in the
range of a high biofilm forming (HBF) control strain, and all strains had significantly higher biofilm
formation than that of a low biofilm forming (LBF) control strain (p < 0.01). At 8 ◦C, all strains,
including the HBF control strain, were impaired in their biofilm forming capacity and hence, no
significant differences between the strains from different complexes, nor between the strains isolated
from the meat processing facility vs. the control strains, were found (Figure 2).
2.3. Tolerance to Benzalkonium Chloride
Benzalkonium chloride is a commonly used disinfectant in the food industry and resistance
against BC might contribute to the persistence of a strain. One hundred and six out of 124 tested strains
were resistant to 10 µg/mL BC (Figure 3). None of the strains, however, were resistant to the cutoff for
resistance—20 µg/mL BC. A cumulative link model [12] revealed that CC29, CC89, CC8 and CC6 had
a significantly lower tolerance to BC (combined average of 4.5 µg/mL BC) compared to the other CC
in the dataset (combined average of 9.2 µg/mL BC, p < 0.05).
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Figure 3. Minimal inhibitory concentration (MIC) of benzalkonium chlorice (BC) by clonal complex.
The y-axis represents frequency. The colors represent the highest concentration of BC (in µg/mL) at
which confluent gro th as observed after 48 h at 37 ◦C. The x-axis represents the different clonal
complexes. n is the nu ber of data points that were observed for each clonal complex.
A genome- ide search in the 20 sequenced strains revealed the presence of either brcABC [13] or
qacH [14] BC resistance genes in 16 (80%) of t e strai s (Table 1). brcABC genes were prese t in six
strains of CC204 , ectively. qacH was present in four C 21 strains. No strain carried the
emrE [15] BC resist . l strains that carried re istance g nes had t e ighest measured BC
resistance at 10 µg , except strain ILS AS1- 004 which was resistant to 7.5 µg/mL.
2.4. Minimal In i i tration and Minimal Bacter cidal Concentration of Peraceti Acid against
L. monocytogenes
PAA is frequently used as a disinfecta t in the food production environm t with a recommended
final concentrat on between 0.5% and 1%. The meat proc ssing fac lity from which the strains
originated used 0.8% PAA as a sanitizer; we therefore hyp thesized that strains f om this collective
might have adapted to PAA over time.
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The MIC was between 0.1% and 0.2% for all strains and the MBC was between 1.2% and 1.6%
(Figure 4, Supplementary File 1). Since the strains were isolated up to four years apart, these data
strongly suggest no adaptation to PAA over time.
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Figure 4. Tolerance to peracetic acid (P ). The x-axis represents the clonal complexes, the y-axis
the frequency. Study strains—strains isolated from the food processing facility; comparative
strains—strains from the same CC but isolated from unrelated sources. (a) Minimal inhibitory
concentration (MIC) for PAA in BHI, at 37 and 8 ◦C. (b) Minimal bactericidal concentration (MBC) for
PAA by medium, BHI—brain heart infusion; water—tap water.
All further analyses were performed in a subset of strains that were chosen to represent all four
years of collection and were divided over the most frequent clonal complexes CC9 (n = 6), CC204
(n = 4), CC121 (n = 3), CC6 (n = 2) and CC20 (n = 1). To test whether the strains had an unusually high
resistance to PAA, a comparison was made to L. monocytogenes strains from unrelated sources that
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belonged to the same clonal complexes [CC9 (n = 4), CC204 (n = 3), CC121 (n = 1) and CC6 (n = 1)]
(Table 1). The minimal bactericidal concentration (MBC) of the strains was between 1.2% and 1.6% with
no difference between the clonal complexes or between the strains isolated from the meat processing
facility versus the control strains (Figure 4a). Therefore, the strains from the meat processing facility
showed no increased tolerance to PAA.
To test whether the availability of protein compounds in the test medium affected the outcome,
the MBC was compared with PAA in tap water and PAA in brain heart infusion (BHI). The MBC of
PAA in tap water was 0.1–0.4% and, therefore, lower compared to the PAA BHI (p < 0.05) (Figure 4b),
indicating that protein affects the effectiveness of PAA and that there is a protein error for PAA.
We further assessed whether the incubation temperature influenced the outcome, which would
indicate that PAA has a cold error. While MBC values were generally a better indicator for disinfection,
we used MIC measurements to address this question because they allowed us to test the effects of cold
exposure over a longer time than MBC measurements. The MIC for PAA was 0.2% for all strains, regardless
of incubation at 4 ◦C or 37 ◦C, suggesting no evidence for a cold error for PAA against L. monocytogenes.
3. Discussion
In this study, we showed that several clonal populations of L. monocytogenes persisted in a meat
processing facility in Switzerland for at least four years. The persistent strains belonged to CC9, CC204
and CC121. The dominant CC9 and CC121 have previously been shown to be overrepresented in food
processing facilities in France [16], Spain [17], Switzerland [18], and all over Europe [19]. CC204 on
the other hand has only been sporadically isolated from food processing facilities [18] and human
patients [20].
Strains from the facility formed biofilm in the range of a high biofilm former. However, no
difference was found between the individual strains isolated from the facility, nor between clonal
complexes. Subtle differences between clonal complexes might be revealed by replacing the 96-well
format biofilm screening protocol used in this study [21] with more labor-intensive procedures, such
as culturing biofilms on stainless steel coupons [22], in a follow-up study. Contradictory results have
been found by other authors: Some studies showed that persistent strains of L. monocytogenes formed
more biofilm than presumed non-persistent strains [11], and persistent strains were more efficient in
attaching to surfaces during a short contact time [23]. Others did not observe a difference between
persistent vs. presumed non-persistent strains [24], and the ability of L. monocytogenes to form true
biofilms at all has been critically questioned by some authors [25]. Given the high biofilm forming
capacity we found in the strains of L. monocytogenes isolated from this meat processing facility, biofilm
formation may have contributed to persistence.
The overrepresentation of CC121 in food processing environments has often been explained
with their higher resistance to BC due to the presence of the qacH or brcABC genes that encode efflux
pumps [26]. Confirming this, all CC121 strains that were sequenced in this study were positive for
qacH. Moreover, 80% of all sequenced strains carried either qacH or brcABC. Given the clonal structure
of the CC121, CC9 and CC204 strains in this collection and their uniform resistance to 10 µg/mL BC,
it is reasonable to assume that most strains in this collection carried either qacH or brcABC. However,
tolerance to 10 µg/mL BC is below the typical in-use concentrations of BC (500–1000 µg/mL) [27],
indicating that BC should be active against the strains in this study.
In contrast, PAA was routinely used for disinfection in the facility, at a final concentration of 0.8%.
Our data showed that the MBC (1.2–1.6%) and the MIC (0.1–0.2%) values were close to or above this
concentration, to ensure efficient disinfection. Experiments without nutrients in the medium showed
that even in the absence of proteins the MBC, between 0.2% and 0.4%, was still very close to the
recommended concentration for use. Under real-life conditions, when disinfecting larger areas, it is
likely that the concentration of the disinfectant becomes diluted through residual washing water and
that residual organic matter is present. It is also likely that contact times differ due to run-off or delayed
reach of hard to clean niches, which in this case would lead to ineffective concentrations of PAA.
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Different strains of L. monocytogenes also exhibited high MBCs for PAA in the range of up to
0.5% [28–31]. In contrast, others concluded that PAA was able to significantly reduce L. monocytogenes
from multispecies biofilms at 0.15% [32] and 0.3% [30], respectively. The MIC of PAA for other
organisms seemed to be much lower, in the range of 0.01–0.03% for Gram-positive and Gram-negative
flora isolated from citrus fruit [33], 0.0003% for Escherichia coli, Staphylococcus aureus, Pseudomonas
aeruginosa [34], and 0.0001–0.001% for P. aeruginosa, S. aureus, E. coli, and S. epidermidis [35]. Given
the high tolerance of L. monocytogenes against PAA found in our data and by others, the ability of
PAA to reduce L. monocytogenes from biofilms may primarily have been due to the elimination of the
supporting flora in multispecies biofilms.
Our data confirm the absence of adaptation of L. monocytogenes to PAA found in other work that
found no adaptation over several hundred generations when L. monocytogenes were exposed to an
industrial disinfectant containing PAA and hydrogen peroxide [36].
Taken together, these experiments show that the concentration of 0.8% PAA used by the facility
is insufficient to ensure safe production standards with regard to L. monocytogenes. However, PAA
is a valuable option for disinfection due to its effectiveness against most bacteria, fungi and viruses,
the absence of a cold error, its status as GRAS, and its colorless and odorless properties, but only
when L. monocytogenes is not a major concern. Since PAA at concentrations above 1% is corrosive
to equipment and irritating to the eyes, via fumes, an alternative disinfectant regimen should be
considered in food production facilities that struggle to control L. monocytogenes in their environment.
4. Material and Methods
4.1. Bacterial Strains and Preparation of Bacterial Cultures
The hygiene-monitoring program of the meat-producing facility entailed product samples and
swabs of the production environment such as floor drains, trolleys, elevators, cold room floors, scales,
production and packaging lines, toilet drains and toilet floors or doors between production sections.
All samples were tested for L. monocytogenes using the “Assurance Genetic Detection System” (GDS,
Biocontrol, Nieuwerkerk aan den IJssel, The Netherlands) according to the protocol. In short, swabs or
samples were incubated in Half Frazer Broth (HFB, BioRad, Marne-la-Coquette, France) at 30 ◦C for
48 h. L. monocytogenes were further enriched on magnetic beads and then identified via a kit-specific
PCR in an “Assurance GDS Rotor-Gene” cycler. To obtain single colonies, the enriched HFB was
streaked on Oxoid chromogenic Listeria agar (OCLA) plates (Oxoid, Pratteln, Switzerland) and
incubated at 37 ◦C for 24 h. All strains were kept in 15% glycerol stocks at –80 ◦C.
To obtain overnight cultures for experiments, the strains were streaked on BHI agar (Oxoid,
Pratteln, Switzerland) and incubated overnight at 37 ◦C. A single colony was inoculated into 5 mL BHI
and incubated for 18 h overnight at 37 ◦C with shaking at 200 RPM in a shaking incubator (Edmund
Buehler SM30/TH30 combination, Huber AG, Reinach, Switzerland). To obtain exponential phase
cultures with an OD590 of 0.4, 50 µL of the overnight culture was subcultivated into 5 mL of fresh BHI
and incubated for 3 h at 37 ◦C with shaking at 200 rpm.
4.2. Serogrouping by qPCR
DNA was isolated from 1 mL overnight cultures using the DNeasy Blood and Tissue Kit (Qiagen,
Hilden, Germany) and eluted in 10 mM Tris pH 7.3. The DNA concentration was measured with a
Nanodrop 1000 (Thermo Fisher Scientific, Basel, Switzerland) and PCR templates were standardized
to 105 copies per 1 µL by dilution in fresh 10 mM Tris. Multiplex qPCRs were performed according to
Vitullo et al. [37], with the following modifications: Instead of a triplex-PCR we performed the qPCR
as duplex with PUC19 [38] as an internal control on the third channel. Primers and probes according
to Vitullo et al. (37) (Table 2) were obtained from Sigma-Aldrich (Buchs, Switzerland), and used at a
final concentration of 0.4 µM for the primer and 0.2 µM for the probe.
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Cycling conditions for the two-step PCR on a LightCycler 2.0 (Roche Science, Rotkreuz,
Switzerland) were as follows: 5 s at 95 ◦C, followed by 40 cycles of 45 s at 95 ◦C and 45 s at 60 ◦C.
4.3. Multi Locus Sequence Typing (MLST)
MLST was performed on all 124 strains according to Ragon et al. [39]. All primers (Table 2)
were ordered from Microsynth (Balgach, Switzerland). The fragment sizes were confirmed by
gel-electrophoresis, the products were sequenced by Microsynth (Balgach Switzerland), assembled
in Geneious (Version 11.1.4, Biomatters, Newark, NJ, USA) and analyzed using the website of the
Institute Pasteur (http://bigsdb.pasteur.fr/listeria/listeria.html).
4.4. Whole Genome Sequencing
Based on the MLST results, a selection of 20 strains (Table 1) were Illumina sequenced. DNA was
extracted, as for the MLST. Sequencing libraries were prepared using the Illumina Nextera DNA Flex
chemistry and sequenced on an Illumina MiniSeq (Illlumina, San Diego, CA, USA) with a minimal
coverage of 30 ×. After quality control with FastQC (http://www.bioinformatics.babraham.ac.uk/
projects/fastqc/), the reads were assembled with Spades 3.12.0 [40]. Core-genome multilocus sequence
typing (cgMLST) was performed in the software package SeqSphere 4.1.9 (Ridom, Münster, Germany).
Assembled genome sequences were imported and blasted against 1701 genes of the seed genome
EGD-e, using the standard settings [10]. A minimal spanning tree was produced in SeqSphere with the
options “ignore missing values pairwise” and “discard genomes with >3% missing genes”. Strains
with less than 10 different alleles were considered to belong to the same complex.
4.5. Biofilm Formation
The 15 strains that represented the four clonal complexes that seemed to persist in the factory
(CC9 (n = 9), CC204 (n = 2), CC121 (n = 2)), (CC6 (n = 2)) were chosen for biofilm assays, according
to the protocol published by Harvey et al. with minor changes [21]. A single colony was inoculated
into 5 mL of tryptone soy broth (TSB, from Fluka, obtained from Sigma-Aldrich, Buchs, Switzerland),
incubated for 20 h at 30 ◦C with shaking at 200 rpm, subcultured 1:250 into fresh TSB, and incubated
for an additional 20 h at 30 ◦C with shaking at 200 rpm. The resulting cultures were adjusted to
an OD600 of 1.0, diluted 1:80 in TSB and added to 96-well plates, which were incubated for 96 h at
22 ◦C, or for 168 h at 8 ◦C, respectively. Biofilms were then washed three times with distilled water,
stained with crystal violet, and washed five times with distilled water. The remaining crystal violet
was dissolved in ethanol and the OD600 was measured in a Synergy plate reader (BioTek, Lucern,
Switzerland). Control strains that were high and low biofilm formers (Institute for Food Safety and
Hygiene, Zurich; unpublished results) (Table 1) were included in each experiment.
4.6. Tolerance to Benzalkonium Chloride
MICs for BC were determined for all 124 strains included in this study, as per the protocol of
Meier et al. with minor changes [26]. Five µL of an exponential phase culture were spotted on BHI
plates containing BC at 0, 2.5, 5.0, 7.5, 10.0, 15.0, 20.0, 25.0 and 30.0 µg/mL (Sigma Aldrich, Buchs,
Switzerland). The plates were incubated for 48 h at 37 ◦C. Strains were considered resistant to the
concentration of BC on which confluent growth was observed. The cutoff for resistance was set,
according to Langsrud et al. [41], as double the value of the lowest concentration that inhibited growth
in >50% of the tested strains.
All sequenced genomes were searched for the qacH, brcABC and emrE BC resistance genes using
BLASTP 2.7.1+ [42] with the standard settings and an e-value cutoff of 10−20.
Pathogens 2019, 8, 32 13 of 16
4.7. Minimal Inhibitory Concentration and Minimal Bactericidal Concentration of Peracetic Acid against
L. monocytogenes
These assays were performed in PAA diluted in BHI to mimic a worst case scenario that assumed
incomplete cleaning of organic matter from surfaces before disinfection, and to assess the overall effect
of PAA on bacteria within an otherwise favorable environment. To determine the influence of the
protein in BHI on the outcome, some of the assays were additionally performed in PAA diluted in tap
water (City of Zürich, supplementary file 2). First, the MIC and MBC for PAA were determined in a
screening of all 124 strains. Given the clonal nature of much of the strain collection, we then compared
the resistance to PAA in detail in a subset of the strains: CC9 (n = 6), CC204 (n = 4), CC121 (n = 3),
CC6 (n = 2) and CC20 (n = 1). A control dataset contained strains from unrelated sources: CC9 (n = 4),
CC204 (n = 3), CC121 (n = 1) and CC6 (n = 1) (Table 1).
To obtain the MBC values, serial dilutions were prepared to obtain final PAA concentrations of
2.8%, 2.4%, 2.0%, 1.6%, 1.2%, 0.8%, 0.4%, 0.2%, 0.1% and 0.05%. Next, 190 µL of these dilutions were
added to 96-well plates and cooled to 4 ◦C. Then, exponential phase cultures were diluted in 0.9%
NaCl and 10 µL were added to each well to achieve an inoculum of approximately 5 × 102 CFU/well
for the dilution rows in BHI and 5 × 104 CFU/well for the dilution rows in water. The plates were
incubated for 20 min at 4 ◦C. After incubation, the wells were mixed by pipetting and 20 µL were
washed in 180 µL 0.9% NaCl in a fresh 96-well plate. These plates were centrifuged at 3220 g for 5 min,
the supernatant was discarded, and the cells were resuspended in 20 µL 0.9% NaCl. Next, 10 µL of
each well was spotted on the edge of a BHI agar plate and run down the plate by tilting [43]. These
plates were incubated for either 7 days at 8 ◦C, to mimic the conditions in a food processing plant, or
for 48 h at 37 ◦C, to provide more favorable growth conditions. Surviving bacteria were enumerated by
direct colony count and the MBC was defined as the concentration of PAA that produced no colonies.
To determine the MIC, the serial dilution plates were incubated at 37 ◦C for 48 h and at 8 ◦C for 7 days.
The MIC was defined as the concentration of PAA that allowed for no visible growth [44].
4.8. Statistical Analysis
All of the experiments were performed in triplicate unless otherwise indicated.
The results were analyzed in RStudio Version 1.1.456 (RStudio, Boston, MA, USA)) and all
statistical analyses are provided as a supplementary file (Supplementary File 1). In short, a linear
mixed effects model, using lmer in a LmerTest [45], was modelled to the biofilm data and lsmeans was
used to create contrasts [46]. A cumulative link model was calculated for the BC and PAA data using
polR in MASS [47], and model selection was done with stepAIC in MASS [47]. All graphics were done
using ggplot2 [48].
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